oral glp-1 medications approved BREAKING: The FDA has the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Comparing Ozempic, Wegovy and Other

Nearly 40% of adults age 60 and older qualified as obese in 2023, according to the Centers for Disease Control and Prevention

They shut down the fat-tissue inflammation factory

Were coming back to these products that have been ineffective in the past, Alan said

Potent body weight loss and efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIP triple-agonist (HM15211)

The capsules and gummies are widely available online without a prescription and promise to help with weight management, cravings and appetite control

If you have questions about compounded alternatives, your physician can walk through the current regulatory landscape and help you weigh the tradeoffs at your consultation